PLG Scribes Target Independent Clinicians

This shows that the fastest path in AI medical scribes is not always better software, it is choosing a buyer you can reach without asking an EHR for permission. Freed and Heidi win early by selling a $99 per month, or free entry product directly to solo doctors and very small practices, where the clinician can start using the tool immediately, copy the note into the chart, and avoid the long procurement, security review, and revenue sharing that come with hospital and Epic centered distribution.

• The split is really SMB versus enterprise. In small practices, the doctor is the user and buyer, so PLG works. In hospitals, the buyer is IT, compliance, and executives, which pushes scribes into formal BAAs, EHR integration work, and slow enterprise sales instead of self serve adoption.
  1 sacra 2 sacra 3 definitivehc
• Epic access is valuable, but costly. Epic covers about 37.7% of the U.S. hospital market, and Abridge used an Epic partnership to reach 60,000 plus clinicians and about $100M ARR by May 2025. The tradeoff is giving Epic equity and ongoing revenue share, which strengthens distribution but reduces independence.
  2 sacra 3 definitivehc 5 sacra
• Freed and Heidi are built for the fragmented long tail that Epic does not control. Freed sells individual plans at $99 per month, while Heidi offers a free forever tier and paid upgrades. That pricing makes sense for practices with only a handful of clinicians, but also means expansion depends on serving many small accounts and gradually adding integrations.
  4 getfreed 6 heidihealth 1 sacra

Going forward, the market is likely to separate into two lanes. Enterprise scribes will keep clustering around Epic, Cerner, and large health systems, while PLG players keep aggregating independent clinicians first, then move into pre charting, coding, and other adjacent workflows to raise revenue per doctor before deeper EHR integration becomes unavoidable.